arrow
V

Valentino D'Onofrio

Ghent University
H指数:12
被引数:468

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

A unified network systems approach uncovers a core program underlying T follicular helper cell differentiation

一种统一的网络系统方法揭示了T滤泡辅助细胞分化的核心程序

2026-07-220
OA
A Novel Carbohydrate Fatty-Acid Monosulphate Ester, Squalane-in-Water Adjuvant Is Safe and Enhances Inactivated Influenza Vaccine Immunogenicity in Older Adults

一种新型碳水化合物脂肪酸单硫酸酯,角鲨烷-水佐剂安全且能增强老年人群灭活流感疫苗的免疫原性

2026-03-030
OAAI
A first-in-human Phase 1/1b randomized trial evaluating the safety and immunogenicity of a respiratory syncytial virus (RSV) virus-like particle subunit vaccine (IVX-121) in healthy young and older adults

一项首次人体I/1b期随机试验,评估呼吸道合胞病毒(RSV)病毒样颗粒亚单位疫苗(IVX-121)在健康年轻和老年成人中的安全性和免疫原性。

2026-03-030
OA
AS04 drives superior cross-protective antibody response by increased NOTCH signaling of dendritic cells and proliferation of memory B cells

AS04通过增强树突状细胞的NOTCH信号和记忆B细胞的增殖,驱动更优的交叉保护性抗体应答

2025-07-260
OA
Safety and immunogenicity of the live-attenuated hRVFV-4s vaccine against Rift Valley fever in healthy adults: a dose-escalation, placebo-controlled, first-in-human, phase 1 randomised clinical trial
2024-11-011
PRE
Safety and Immunogenicity of a Carbohydrate Fatty Acid Monosulphate Ester Adjuvant Combined with a Low-Dose Quadrivalent Split-Virion Inactivated Influenza Vaccine: A Randomised, Observer-Blind, Active-Controlled, First-in-Human, Phase 1 Study
2024-09-101
OAAI
Organ-specific genome diversity of replication-competent SARS-CoV-2 (vol 12, 6612, 2021)
2022-10-212
OAAI
Studying the clinical, radiological, histological, microbiological, and immunological evolution during the different COVID-19 disease stages using minimal invasive autopsy
2022-01-2510
OAAI
Organ-specific genome diversity of replication-competent SARS-CoV-2

具有复制能力的SARS-CoV-2的器官特异性基因组多样性

2021-11-1649
OAAI